University of Chicago Medicine Cardiac Amyloidosis Program | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
University Of Chicago Medicine Cardiac Amyloidosis Program

University of Chicago Medicine Cardiac Amyloidosis Program

5841 S. Maryland Avenue
Chicago, Illinois, United States
Phone   Web  

The University of Chicago Medicine is one of only a few institutions in the country that specialize in cardiac amyloidosis. Their Cardiac Amyloidosis Program includes a team of multidisciplinary experts who have the experience to diagnose and treat this complex condition.

University of Chicago Medicine is committed to offering patients the best quality of life during and after treatment and they are doing groundbreaking research into the disease and its causes, so that they can identify high-risk patients and develop effective, long-term treatments. They also offer genetic testing for patients and their families.

While several types of amyloidosis affect the heart, their cardiologists primarily treat the following two types of Amyloidosis:

• AL amyloidosis (also called primary amyloidosis.

• TTR amyloidosis 

The team includes healthcare professionals in the following areas:

Cardiology:
Amit R. Patel, MD; Nitasha Sarswat, MD

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2025 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close